Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection-Reference-Cited by-同舟云学术

Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection

Published:2016-10-11 Issue:1 Volume:14 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Jalanka Jonna,Mattila Eero,Jouhten Hanne,Hartman Jorn,de Vos Willem M.,Arkkila Perttu,Satokari Reetta

Funder

Biotieteiden ja Ympäristön Tutkimuksen Toimikunta

Finnish foundation for Gastroenterological Research

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12916-016-0698-z.pdf

Reference54 articles.

1. Kelly CP, LaMont JT. Clostridium difficile – More difficult than ever. New Engl J Med. 2008;359(18):1932–40.

2. Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, Gorbach S, Sears P, Shue YK, OPT-80-003 Clinical Study Group. Fidaxomicin versus vancomycin for Clostridium difficile infection. New Engl J Med. 2011;364(5):422–31.

3. Honda H, Dubberke ER. The changing epidemiology of Clostridium difficile infection. Curr Opin Gastroenterol. 2014;30(1):54–62.

4. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 2009;7(7):526–36.

5. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108(4):478–98. quiz 499.

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A meta-analysis of randomized controlled trials evaluating the effectiveness of fecal microbiota transplantation for patients with irritable bowel syndrome;BMC Gastroenterology;2024-07-05

2. Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson's disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial;eClinicalMedicine;2024-05

3. Long- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trial;Gut Microbes;2024-03-13

4. Aged oolong tea alleviates dextran sulfate sodium-induced colitis in mice by modulating the gut microbiota and its metabolites;Food Chemistry: X;2024-03

5. Microbiota and mucosal gene expression of fecal microbiota transplantation or placebo treated patients with chronic pouchitis;Gut Microbes;2024-01-12